학술논문

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations
Document Type
article
Source
Neurology. 81(15)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Genetics
Frontotemporal Dementia (FTD)
Dementia
Brain Disorders
Clinical Research
Neurosciences
Alzheimer's Disease Related Dementias (ADRD)
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Acquired Cognitive Impairment
2.1 Biological and endogenous factors
Aetiology
Neurological
Aged
Aged
80 and over
Autopsy
C9orf72 Protein
Cohort Studies
DNA Repeat Expansion
Female
Follow-Up Studies
Genetic Predisposition to Disease
Genetic Testing
Humans
Intercellular Signaling Peptides and Proteins
Male
Microtubule-Associated Proteins
Middle Aged
Neurodegenerative Diseases
Phenotype
Progranulins
Proteins
tau Proteins
Cognitive Sciences
Neurology & Neurosurgery
Clinical sciences
Language
Abstract
ObjectiveTo identify potential genetic modifiers contributing to the phenotypic variability that is detected in patients with repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), we investigated the frequency of these expansions in a cohort of 334 subjects previously found to carry mutations in genes known to be associated with a spectrum of neurodegenerative diseases.MethodsA 2-step protocol, with a fluorescent PCR and a repeat-primed PCR, was used to determine the presence of hexanucleotide expansions in C9ORF72. For one double mutant, we performed Southern blots to assess expansion sizes, and immunohistochemistry to characterize neuropathology.ResultsWe detected C9ORF72 repeat expansions in 4 of 334 subjects (1.2% [or 1.8% of 217 families]). All these subjects had behavioral phenotypes and also harbored well-known pathogenic mutations in either progranulin (GRN: p.C466LfsX46, p.R493X, p.C31LfsX35) or microtubule-associated protein tau (MAPT: p.P301L). Southern blotting of one double mutant with a p.C466LfsX46 GRN mutation demonstrated a long repeat expansion in brain (>3,000 repeats), and immunohistochemistry showed mixed neuropathology with characteristics of both C9ORF72 expansions and GRN mutations.ConclusionsOur findings indicate that co-occurrence of 2 evidently pathogenic mutations could contribute to the pleiotropy that is detected in patients with C9ORF72 repeat expansions. These findings suggest that patients with known mutations should not be excluded from further studies, and that genetic counselors should be aware of this phenomenon when advising patients and their family members.